Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37,435,082
-
Number of holders
-
95
-
Total 13F shares, excl. options
-
27,293,895
-
Shares change
-
+786,337
-
Total reported value, excl. options
-
$265,303,644
-
Value change
-
+$8,398,552
-
Number of buys
-
38
-
Number of sells
-
-50
-
Price
-
$9.72
Significant Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q3 2020
105 filings reported holding LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock as of Q3 2020.
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) has 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27,293,895 shares
of 37,435,082 outstanding shares and own 73% of the company stock.
Largest 10 shareholders include Legion Partners Asset Management, LLC (2,904,340 shares), WYNNEFIELD CAPITAL INC (2,875,300 shares), Russell Investments Group, Ltd. (2,819,250 shares), DIMENSIONAL FUND ADVISORS LP (2,297,221 shares), VANGUARD GROUP INC (2,078,356 shares), BlackRock Inc. (1,939,955 shares), HEARTLAND ADVISORS INC (1,236,815 shares), INVESTMENT COUNSELORS OF MARYLAND LLC (1,043,996 shares), Cove Street Capital, LLC (660,182 shares), and Pacific Ridge Capital Partners, LLC (591,410 shares).
This table shows the top 95 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.